CJC-1295 + Ipamorelin Dosage: Doses Studied, Units and Chart
What doses of CJC-1295 + Ipamorelin have been used in published research, how they convert to syringe units, and what is still unknown.
- Doses studied
- 11 studies
- with a stated dose, listed below
- Frequency
- Varies by study
- as used in studies
- Half-life
- 2 hours terminal half-life
- intravenous infusion (15 min), in people · Pharmaceutical research 1999, PMID 10496658
- Vial sizes sold
- 10 mg
Doses used in published studies
No study has tested CJC-1295 + Ipamorelin itself. These are the doses used in studies of each ingredient, strongest design first. Animal doses are labelled and do not translate directly to people. None of them is a recommendation.
| Dose | Frequency and route | Study type | Source |
|---|---|---|---|
| Ipamorelin: 0.03 mg/kg ipamorelin | twice daily · intravenous infusion · postoperative day 1 to 7 or hospital discharge | Human RCTn = 117 | International journal of colorectal disease 2014, PMID 25331030 |
| CJC-1295: Four ascending single doses (first study); two or three weekly or biweekly doses (second study) | single, weekly or biweekly · subcutaneous · 28 and 49 days | Human RCT | The Journal of clinical endocrinology and metabolism 2006, PMID 16352683 |
| Ipamorelin: 4.21, 14.02, 42.13, 84.27 and 140.45 nmol/kg | single · intravenous infusion over 15 minutes | Human RCT | Pharmaceutical research 1999, PMID 10496658 |
| CJC-1295: 60 or 90 microg/kg CJC-1295 (single injection) | single · injection (route not stated in abstract) · 1 wk to follow-up | Human uncontrolled trial | The Journal of clinical endocrinology and metabolism 2006, PMID 17018654 |
| Ipamorelin: 1-3 mg/kg | every 24 h · intraperitoneal · up to 72 h | Animal · ferret (not a human result) | Physiology & behavior 2024, PMID 39043357 |
| Ipamorelin: 0.014-0.14 umol/kg | single · intravenous | Animal · rat (not a human result) | Journal of experimental pharmacology 2012, PMID 27186127 |
| Ipamorelin: 0.01-1 mg/kg | single dose or four doses a day at 3-h intervals for 2 days · intravenous bolus · 48 h | Animal · rat (not a human result) | The Journal of pharmacology and experimental therapeutics 2009, PMID 19289567 |
| CJC-1295: 2 microg CJC-1295 | every 24, 48 or 72 h · not stated · 5 wk | Animal · mouse (not a human result) | American journal of physiology. Endocrinology and metabolism 2006, PMID 16822960 |
| Ipamorelin: 100 microg/kg | three times daily · subcutaneous · 3 months | Animal · rat (not a human result) | Growth hormone & IGF research 2001, PMID 11735244 |
| Ipamorelin: 0.5 mg/kg per day | continuous · subcutaneous (osmotic minipump) · 12 weeks | Animal · rat (not a human result) | The Journal of endocrinology 2000, PMID 10828840 |
| Ipamorelin: 0, 18, 90 and 450 microg/day | three times daily · subcutaneous · 15 days | Animal · rat (not a human result) | Growth hormone & IGF research 1999, PMID 10373343 |
Dose to syringe units
For a 10 mg vial mixed with 2 mL of bacteriostatic water (5 mg/mL), on a U-100 syringe. These are reference amounts for the math, not suggested doses.
- 0.25 mg
- 5 u
- 0.5 mg
- 10 u
- 1 mg
- 20 u
- 2 mg
- 40 u
- 2.5 mg
- 50 u
- 5 mg
- 100 u
Before anyone considers it
- CJC-1295 + Ipamorelin is Not FDA approved · research blend; research-chemical versions are not the approved drug.
- Compounded and research-chemical versions are not the approved product and are not checked by the FDA for identity, purity or dose.
- Reconstitution math (mg vs mcg, units vs mL) is the most asked question in peptide forums. Check every number twice.
- People who are pregnant, breastfeeding, or have a chronic condition need medical advice first.
Common questions
How many units is 1 mg of CJC-1295 + Ipamorelin?
It depends on the water added. A 10 mg vial with 2 mL of water gives 5 mg/mL, so 1 mg is 20 units on a U-100 syringe. Use the calculator for other mixes.
Is CJC-1295 + Ipamorelin FDA approved?
CJC-1295 + Ipamorelin is Not FDA approved · research blend. Products sold as research chemicals are not the approved drug and are not checked by the FDA.
More on CJC-1295 + Ipamorelin
Side effectsWhat labels and studies report, and what is unknown.Blend calculatorSplit a blend vial into per-peptide amounts and units.ResultsStudy outcomes and when they were measured.PricePrice per mg and per week from dated listings. No vendor links.Legal statusFDA, compounding and WADA status with dates.How to injectSites, syringe types and hygiene, step by step.
Sources
- 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
- 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
- 3Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.International journal of colorectal disease · 2014PMID 25331030Accessed 2 Oct 2026
- 4Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.The Journal of clinical endocrinology and metabolism · 2006PMID 16352683Accessed 2 Oct 2026
- 5Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.Pharmaceutical research · 1999PMID 10496658Accessed 2 Oct 2026
- 6Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.The Journal of clinical endocrinology and metabolism · 2006PMID 17018654Accessed 2 Oct 2026
- 7The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.Physiology & behavior · 2024PMID 39043357Accessed 2 Oct 2026
- 8Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus.Journal of experimental pharmacology · 2012PMID 27186127Accessed 2 Oct 2026
- 9Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus.The Journal of pharmacology and experimental therapeutics · 2009PMID 19289567Accessed 2 Oct 2026
- 10Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.American journal of physiology. Endocrinology and metabolism · 2006PMID 16822960Accessed 2 Oct 2026
- 11The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2001PMID 11735244Accessed 2 Oct 2026
- 12The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats.The Journal of endocrinology · 2000PMID 10828840Accessed 2 Oct 2026
- 13Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 1999PMID 10373343Accessed 2 Oct 2026
Found an error? Report a correction.